Primary Description
Trade name:
Elocon
International name:
Mometasone (Mometasone)
Group affiliation:
Glucocorticosteroid for local application
Description of the active substance (INN):
Mometasone
Dosage form:
cream for external use, ointment for external application, a solution for external use
Pharmacological actions:
CORTICOSTEROID for topical application. Has anti-inflammatory and antiallergic action. It inhibits the release of mediators of inflammation. Increases products lipokortina, which is a inhibitors fosfolipaza A2, which causes decrease of arachidonic acid. Prevents the accumulation of neutrophils, which reduces inflammatory exudate and production of the cytokines, inhibits the migration of macrophages, leads to the reduction of the processes of infiltration and granulation. Reduces inflammation by reducing the formation of the substance of chemotaxis of (influence on "late" allergic reactions), inhibits the development of an "immediate" allergic reaction (due to inhibition of metabolites arahidonova acid and the reduction of the release of mast cell mediators of inflammation). The daily application of the cream of children over 2 years of age with allergic dermatitis, the therapeutic effect is manifested for three weeks.
Indications:
Psoriasis, atopic dermatitis, a simple chronic herpes (limited neurodermatitis, eczema, zudaschie medicine, insect bites, burns of I degree, the sun burns red lichen planus, discoid lupus erythematosus.
Contraindications:
Hypersensitivity, lactation, children's age (up to 2 years). C caution. Pregnancy, tuberculosis (active and latent forms), fungal, bacterial, systemic viral infections, infections caused by Herpes simplex with the defeat of the eye. Long-term treatment of systemic CORTICOSTEROIDS.
Side effects:
Burning, itching, parestesia, folliculitis, acne, skin atrophy, gipertrihoz, hypopigmentation, perioralny dermatitis, allergic contact dermatitis, maceration of the skin, the accession of secondary infection, scars, potnitsa.Peredozirovka. Symptoms: oppression of the hypothalamic-pituitary-adrenal system (including adrenal insufficiency). Treatment: symptomatic. Discontinue the drug gradually. Correction of electrolyte disorders.
Way of administration and dosage:
External, adults and children from 2 years. Cream and ointment applied on the affected areas of skin, thin layer 1-2 times a day. Lotion in the amount of several drops are at the affected areas (including the scalp and rubbed the soft motions to complete absorption.
Special instructions:
Do not use in ophthalmology. Regularly monitor the function of the adrenal glands. When side effects treatment should be discontinued and assign the appropriate therapy. With the accession of secondary infection and antimicrobial therapy. With long-term use, on the wide surface of the possible development of systemic side effects. In children, they are developing faster (suppression of the functions of hypothalamic-pituitary-adrenal system, decrease excretion of STG). Administered in pregnancy in cases where the presumed benefit to the mother outweighs the potential risk to the fetus; the use of small doses and apply a short time. If necessary, the appointment of the drug during lactation should stop breastfeeding.
Description of the drug Elocon is not intended for treatment without the participation of a doctor.
Elocon
International name:
Mometasone (Mometasone)
Group affiliation:
Glucocorticosteroid for local application
Description of the active substance (INN):
Mometasone
Dosage form:
cream for external use, ointment for external application, a solution for external use
Pharmacological actions:
CORTICOSTEROID for topical application. Has anti-inflammatory and antiallergic action. It inhibits the release of mediators of inflammation. Increases products lipokortina, which is a inhibitors fosfolipaza A2, which causes decrease of arachidonic acid. Prevents the accumulation of neutrophils, which reduces inflammatory exudate and production of the cytokines, inhibits the migration of macrophages, leads to the reduction of the processes of infiltration and granulation. Reduces inflammation by reducing the formation of the substance of chemotaxis of (influence on "late" allergic reactions), inhibits the development of an "immediate" allergic reaction (due to inhibition of metabolites arahidonova acid and the reduction of the release of mast cell mediators of inflammation). The daily application of the cream of children over 2 years of age with allergic dermatitis, the therapeutic effect is manifested for three weeks.
Indications:
Psoriasis, atopic dermatitis, a simple chronic herpes (limited neurodermatitis, eczema, zudaschie medicine, insect bites, burns of I degree, the sun burns red lichen planus, discoid lupus erythematosus.
Contraindications:
Hypersensitivity, lactation, children's age (up to 2 years). C caution. Pregnancy, tuberculosis (active and latent forms), fungal, bacterial, systemic viral infections, infections caused by Herpes simplex with the defeat of the eye. Long-term treatment of systemic CORTICOSTEROIDS.
Side effects:
Burning, itching, parestesia, folliculitis, acne, skin atrophy, gipertrihoz, hypopigmentation, perioralny dermatitis, allergic contact dermatitis, maceration of the skin, the accession of secondary infection, scars, potnitsa.Peredozirovka. Symptoms: oppression of the hypothalamic-pituitary-adrenal system (including adrenal insufficiency). Treatment: symptomatic. Discontinue the drug gradually. Correction of electrolyte disorders.
Way of administration and dosage:
External, adults and children from 2 years. Cream and ointment applied on the affected areas of skin, thin layer 1-2 times a day. Lotion in the amount of several drops are at the affected areas (including the scalp and rubbed the soft motions to complete absorption.
Special instructions:
Do not use in ophthalmology. Regularly monitor the function of the adrenal glands. When side effects treatment should be discontinued and assign the appropriate therapy. With the accession of secondary infection and antimicrobial therapy. With long-term use, on the wide surface of the possible development of systemic side effects. In children, they are developing faster (suppression of the functions of hypothalamic-pituitary-adrenal system, decrease excretion of STG). Administered in pregnancy in cases where the presumed benefit to the mother outweighs the potential risk to the fetus; the use of small doses and apply a short time. If necessary, the appointment of the drug during lactation should stop breastfeeding.
Description of the drug Elocon is not intended for treatment without the participation of a doctor.
